Name: ABSCI CORP (ABSI) Stock
Brand: ABSCI CORP
Rating: 5 (3 reviews)

ABSI Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill - Mentions: FLY IDN GURE CMCT ...

Wednesday's after hours session: top gainers and losers

6 days ago - By: Benzinga - Mentions: ZYXI MRSN CMND OTLK ...

12 Health Care Stocks Moving In Thursday's Intraday Session

6 days ago - By: The Motley Fool

Absci (ABSI) Q3 2025 Earnings Call Transcript

7 days ago - By: Benzinga - Mentions: SNDK EGAN KLC KDK ...

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

7 days ago - By: Zacks Investment Research - Mentions: BHST

Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates

7 days ago - By: Absci Corporation

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

7 days ago - By: Absci Corporation

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

10 days ago - By: Zacks Investment Research - Mentions: QURE

uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates

21 days ago - By: Absci Corporation

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

21 days ago - By: Absci Corporation

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

24 days ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

24 days ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

a month ago - By: Absci Corporation

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

a month ago - By: Absci Corporation

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

2 months ago - By: Absci Corporation; Oracle; AMD - Mentions: AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

2 months ago - By: Absci Corporation; Oracle; AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

3 months ago - By: Absci Corporation

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

3 months ago - By: Absci Corporation

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

3 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

3 months ago - By: Absci Corporation

Absci to Participate in Upcoming Investor Conferences

3 months ago - By: The Motley Fool

Absci Sales Fall 54 Percent

3 months ago - By: Zacks Investment Research - Mentions: CLNN

Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates

3 months ago - By: Absci Corporation

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

3 months ago - By: Absci Corporation

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

3 months ago - By: Zacks Investment Research - Mentions: SABS

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

3 months ago - By: Absci Corporation

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

3 months ago - By: Absci Corporation

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

4 months ago - By: Zacks Investment Research - Mentions: AMGN

ABSCI CORP (ABSI) Stock News

ABSI Latest News, Press Relases and Analysis

Wednesday's after hours session: top gainers and losers

12 Health Care Stocks Moving In Thursday's Intraday Session

Absci (ABSI) Q3 2025 Earnings Call Transcript

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

Absci Sales Fall 54 Percent

Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates